Screen shot 2018 10 22 at 4 08 46 pm
Microstegium Vimineum (Japanese Stiltgrass) is an invasive grass species that is currently dominating susceptible ecosystems across the eastern half of the United States. The presence of Japanese Stiltgrass can result in decomposition of plant available carbon (C) and nitrogen (N), limiting the variety of species that thrive within these habitats. N deposition has the ability to influence the composition of plant communities as it can change the concentration of nitrogen within the atmosphere and rhizosphere. Similarly, leaf litter quality influences microbial communities and therefore available nutrients to understory plants. In this study, we are examining the degree at which these factors influence the impact of Japanese Stiltgrass on soil degradation. The study is taking place in the Shawnee National Forest in southern Illinois. 20 pairs of plots consist of 10 low-quality litter (pine dominated) plots and 10 high-quality litter (6 maple-elm and 4 tulip-poplar dominated) plots. Within each pair, three one-square foot subplots are each receiving one of three nitrogen treatments: 8.65 kg N ha-1 yr-1 or high N, 3.46kg N ha-1 yr-1 or low N, and a control of 0 g N m-2 yr-1. It is anticipated that the highest N treatment levels will yield lesser impacts on the soil in all forest cover types. However, we expect to see the greatest suppression of SOM decomposition under pine-dominated forests, as the microbial communities within these stands are more sensitive to higher levels N additions.
Hed 20 0508 figure 1 png
IntroductionThe rapid spread of coronavirus disease 2019 (COVID-19) worldwide raised concerns about its heavy impact on the health care delivery system and forced significant changes in the realities of the clinical practice we are accustomed to. With these changes comes a need for a different approach to outpatient evaluation of common otolaryngology complaints in patients with new symptoms.Recently published set of guidelines for evaluation of head and neck during the COVID-19 pandemic recommended to postpone the management of benign disease including benign salivary or thyroid gland disease.1 In order to limit the chance of COVID-19 infection among patients or health care workers, surveying patients via telephone or telemedicine visit was advised, reserving in-person evaluation for the patients at risk for significant negative outcomes. The challenge is that these measures can only be applied in clear-cut clinical scenarios, when the disease process is most likely benign and the care delivery can be postponed.In cases with a high degree of uncertainty based on available clinical information, many physicians will have to decide how to proceed after initial telemedicine encounter. Clinicians will have to consider how to balance a potential delay in diagnosis, including cancer diagnosis, against the risk of COVID-19 exposure, and may need to exercise their best judgement knowing that for head and neck cancer the risk of progression with cancer care delay is high.2 In this communication, we present our approach to triaging and evaluation of patients with complaints concerning for salivary gland disease.